|

Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Rutgers, The State University of New Jersey1

Indications

  • Gastro-Intestinal Cancer1
  • Cancer1

Hamilton, New Jersey1 trial

sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)

RWJBarnabas Health - Robert Wood Johnson University Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.